Macrophages‐Cancer Membrane‐Encapsulated Metal−Organic Frameworks with Copper‐Depleting Moiety for Mitochondria‐Targeted Therapeutics
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202202986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Weiqun Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Harbin Institute of Technology (Shenzhen), 518055, Shenzhen, China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms, Nanoparticles, MicroRNAs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen University.
Abstract (Originalsprache)
Mitochondria‐targeted therapeutics are an attractive approach against energy‐dependent cancer. However, effective mitochondria organelle therapeutics agents are still highly desirable. Herein, a mitochondria‐targeted therapeutics platform, termed CDM@MUiO‐DP@MCHM, consisting of macrophages‐cancer hybrid membrane (MCHM) encapsulated MUiO‐66 metal−organic frameworks (MOFs) is reported, which is loaded with microRNA (miRNA) biomarker detection probe (DP) for cancer diagnosis and copper‐depleting moiety (CDM) for mitochondrial copper depletion to suppress cancer growth. Using nude mice bearing MCF‐7 as model, after injecting intravenously via the caudal vein of mice, the encapsulation of MCHM can not only greatly enhance the cancer homing‐targeting ability of the nanoparticles (NPs) but also endows the NPs the immune escape capacity to extend the circulation time. The miRNA‐21 biomarker can be detected by the fluorescence signal for diagnosis, while the CDM induced energy deficiency and compromised mitochondria membrane potential, leading to apoptosis of the cancer cell. The good performance of CDM@MUiO‐DP@MCHM suggest the great potential mitochondria organelle therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Science, Harbin Institute of Technology (Shenzhen), 518055, Shenzhen, China.
- School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 150001, Harbin, China.
- Marshall Laboratory of Biomedical Engineering, Precision Medicine and Health Research Institute, School of Biomedical Engineering, Health Science Center, Shenzhen University, 518060, Shenzhen, China.
ORCID-Profile: Haifeng Dong
Förderung
- National Natural Science Foundation of China
- Shenzhen University
Zitieren
APA
Li, W., Dong, M., Li, Y., & Dong, H. (2023). Macrophages‐Cancer Membrane‐Encapsulated Metal−Organic Frameworks with Copper‐Depleting Moiety for Mitochondria‐Targeted Therapeutics. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202202986
Vancouver
Li W, Dong M, Li Y, Dong H. Macrophages‐Cancer Membrane‐Encapsulated Metal−Organic Frameworks with Copper‐Depleting Moiety for Mitochondria‐Targeted Therapeutics. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202202986
BibTeX
@article{Li2023,
author = {Li, Weiqun and Dong, Mingjie and Li, Yingchun and Dong, Haifeng},
title = {Macrophages‐Cancer Membrane‐Encapsulated Metal−Organic Frameworks with Copper‐Depleting Moiety for Mitochondria‐Targeted Therapeutics},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202202986}
}
EUVIMED